Vycor Medical (VYCO) Return on Capital Employed (2011 - 2026)
Vycor Medical (VYCO) posted quarterly Return on Capital Employed of 2.25% for Q1 2026, down 259.0% year-over-year from 1.42% in Q1 2025, and down 158.94% quarter-over-quarter from 0.87% in Q4 2025.
Vycor Medical (VYCO) Return on Capital Employed (2011 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Return on Capital Employed for 16 consecutive years, with 2.25% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 259.0% year-over-year to 2.25%; the TTM figure through Mar 2026 stood at 2.25% (down 259.0% YoY), while the FY2025 annual figure was 0.88%, down 114.0% from the prior year.
- Return on Capital Employed retreated to 2.25% in Q1 2026 per VYCO's latest filing, from 0.87% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 15.61% in Q2 2022 and bottomed at 2.3% in Q3 2025.
- Historically, Return on Capital Employed has averaged 3.51% across 5 years, with a median of 0.34% in 2025.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 2696 bps — and 2024, when it surged 306 bps.
- Vycor Medical's Return on Capital Employed stood at 11.15% in 2022, then tumbled by 112 bps to 1.32% in 2023, then jumped by 120 bps to 0.26% in 2024, then slumped by 429 bps to 0.87% in 2025, then sank by 159 bps to 2.25% in 2026.
- Business Quant data shows VYCO's Return on Capital Employed at 2.25% in Q1 2026, 0.87% in Q4 2025, and 2.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -1.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.25% |
| Dec 31, 2025 | -0.87% |
| Sep 30, 2025 | -2.30% |
| Jun 30, 2025 | -0.61% |
| Mar 31, 2025 | 0.34% |
| Dec 31, 2024 | 0.26% |
| Sep 30, 2024 | 2.63% |
| Jun 30, 2024 | 2.49% |
| Mar 31, 2024 | 0.08% |
| Dec 31, 2023 | -1.32% |
| Sep 30, 2023 | -0.43% |
| Jun 30, 2023 | 1.70% |
| Mar 31, 2023 | 7.50% |
| Dec 31, 2022 | 11.15% |
| Sep 30, 2022 | 14.10% |
| Jun 30, 2022 | 15.61% |
| Mar 31, 2022 | 11.66% |
| Dec 31, 2021 | 20.16% |
| Sep 30, 2021 | 21.74% |
| Jun 30, 2021 | 27.92% |